The workaround many prescribers use: if a non-diabetic patient also has a comorbidity that a GLP-1 drug treats (cardiovascular disease for Wegovy, sleep apnea for Zepbound), the prescriber can request coverage under that indication
This is not a stack you want to miss out on
Llor C, Bjerrum L
Typically those with MTHFR polymorphisms (C677T or A1298C variants reduce methylenetetrahydrofolate reductase activity by 3070%), chronic alcohol use (depletes SAMe and impairs methionine adenosyltransferase), or vegan diets without B12 supplementation
Therapeutic advances in endocrinology and metabolism , 12, 2042018821989238
Taken together, various cell death pathways exist that in physiological conditions take part in the fine processes of development, differentiation, and removal of damaged or unfunctional cells and subcellular structures, or harmful microorganisms